InvestorsHub Logo

sukus

09/16/20 12:07 PM

#307962 RE: abeta #307946

The potential of DCVax-L and Direct to treat other 15 solid tumors should command higher multiple I believe. Hope market makers would eventually support that higher multiple once they are convinced healthy revenues can sustain day to day operation.